USPTO serial 79175636
STAZOLVI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- ROACH, APRIL K
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with STAZOLVI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
MAURY M TEPPER III TEPPER & EYSTER PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2017 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 25, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 25, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 5, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 5, 2017 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 16, 2016 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Oct 15, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 25, 2016 | MAB4 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | — |
| Aug 25, 2016 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Aug 25, 2016 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Aug 25, 2016 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| May 30, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 27, 2016 | RFNP | REFUSAL PROCESSED BY IB | — |
| May 20, 2016 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| May 12, 2016 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| May 12, 2016 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Feb 11, 2016 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 24, 2015 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 7, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 12, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 10, 2015 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 7, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |